• Akouos closes $105m Series B financing pharmaceutical-business-review
    March 05, 2020
    Akouos, Inc., a precision genetic medicine company developing potential gene therapies to restore, improve or preserve hearing, announced it has raised $105 million in an oversubscribed Series B financing.
  • Akouos raises $50M to take hearing loss gene therapy into humans fiercebiotech
    August 08, 2018
    Akouos has raised $50 million to take a gene therapy treatment for hearing loss into the clinic. The Boston-based biotech unveiled the series A round alongside the appointment of a Spark Therapeutics co-founder and other organizational changes.
PharmaSources Customer Service